Are you looking for a life-changing career within pharmaceutical manufacturing?
At Novo Nordisk Manufacturing Kalundborg we have more than 50 years of expertise in large-scale biotech manufacturing. Our 4,500 employees produce half of the world’s insulin, GLP-1, and several biopharmaceutical products, reaching more than 40 million people living with diabetes and other chronic diseases.
From 2022-2029 we will invest 60 billion DKK to expand existing facilities, for the current and future portfolio within serious chronic diseases.
This will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to packaging, with the vast majority being invested in API capacity. With the investment, more than 1200 new jobs will be created.
Daniel Skarum-Kristoffersen | Associate Manager | Novo Nordisk
Daniel works within Purification and has years of experience within Production Support Engineering and management. Daniel holds a master’s degree within Engineering, specializing in Energy, Management and systems, and currently leads a large team of highly skilled international profiles.
Daniel is motivated about being part of new and exciting projects, finding new solutions and professional development – of himself, and for his team members.
About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 54,400 people in 80 countries and markets its products in around 170 countries.
For job seekers | For employers | Join BCF Career Event |
| Register BCF ONLINE | |
Powered by: Hyphen Projects Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 |
© Copyright 2024 by Hyphen Projects